138 related articles for article (PubMed ID: 20932085)
1. A new and preliminary three-dimensional perspective: proteomes of optimization between OSCC and OLK.
He H; Sun G; Ping F; Cong Y
Artif Cells Blood Substit Immobil Biotechnol; 2011 Feb; 39(1):26-30. PubMed ID: 20932085
[TBL] [Abstract][Full Text] [Related]
2. Laser-capture microdissection and protein extraction for protein fingerprint of OSCC and OLK.
He H; Sun G; Ping F
Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(5):208-13. PubMed ID: 19735007
[TBL] [Abstract][Full Text] [Related]
3. A metabonomic approach to the diagnosis of oral squamous cell carcinoma, oral lichen planus and oral leukoplakia.
Yan SK; Wei BJ; Lin ZY; Yang Y; Zhou ZT; Zhang WD
Oral Oncol; 2008 May; 44(5):477-83. PubMed ID: 17936673
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of salivary endothelin-1 levels in oral squamous cell carcinoma and oral leukoplakia.
Hoffmann RR; Yurgel LS; Campos MM
Regul Pept; 2011 Jan; 166(1-3):55-8. PubMed ID: 20727373
[TBL] [Abstract][Full Text] [Related]
5. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
Ogmundsdóttir HM; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
[TBL] [Abstract][Full Text] [Related]
6. Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP.
Kang Y; Chen J; Li X; Luo M; Chen H; Cui B; Wang L; Lv D; Feng Y; Zhang P
Cancer Biomark; 2021; 31(4):317-328. PubMed ID: 33896830
[TBL] [Abstract][Full Text] [Related]
7. Alteration in the expression of cdk4 and cdk6 proteins in oral cancer and premalignant lesions.
Poomsawat S; Buajeeb W; Khovidhunkit SO; Punyasingh J
J Oral Pathol Med; 2010 Nov; 39(10):793-9. PubMed ID: 20618617
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of DARPP-32 in oral premalignant and malignant lesions.
Pimenta FJ; Horta MC; Vidigal PV; De Souza BR; De Marco L; Romano-Silva MA; Gomez RS
Anticancer Res; 2007; 27(4B):2339-43. PubMed ID: 17695523
[TBL] [Abstract][Full Text] [Related]
9. Expression of FAP in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
Li R; Zhang R; Shi X; Jiao X; Li Y; Zhao Y; Liu T; Zhang C
Int Dent J; 2024 Jun; 74(3):581-588. PubMed ID: 38278714
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of salivary and serum lipid peroxidation, and glutathione in oral leukoplakia and oral squamous cell carcinoma.
Metgud R; Bajaj S
J Oral Sci; 2014 Jun; 56(2):135-42. PubMed ID: 24930750
[TBL] [Abstract][Full Text] [Related]
11. Serum metabolomics in oral leukoplakia and oral squamous cell carcinoma.
Sridharan G; Ramani P; Patankar S
J Cancer Res Ther; 2017; 13(3):556-561. PubMed ID: 28862226
[TBL] [Abstract][Full Text] [Related]
12. [Comparative analysis of methylation profiles in tissues of oral leukoplakia and oral squamous cell carcinoma].
Fu J; Su Y; Liu Y; Zhang XY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Apr; 53(4):248-253. PubMed ID: 29690695
[No Abstract] [Full Text] [Related]
13. Metallothionein and p-Akt proteins in oral dysplasia and in oral squamous cell carcinoma: an immunohistochemical study.
Pontes HA; de Aquino Xavier FC; da Silva TS; Fonseca FP; Paiva HB; Pontes FS; dos Santos Pinto D
J Oral Pathol Med; 2009 Sep; 38(8):644-50. PubMed ID: 19453843
[TBL] [Abstract][Full Text] [Related]
14. Expressions of CXCL12/CXCR4 in oral premalignant and malignant lesions.
Xia J; Chen N; Hong Y; Chen X; Tao X; Cheng B; Huang Y
Mediators Inflamm; 2012; 2012():516395. PubMed ID: 22496601
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a new OSCC cell line derived from OLK and identification of malignant transformation-related proteins by differential proteomics approach.
Dong Y; Zhao Q; Ma X; Ma G; Liu C; Chen Z; Yu L; Liu X; Zhang Y; Shao S; Xiao J; Li J; Zhang W; Fu M; Dong L; Yang X; Guo X; Xue L; Fang F; Zhan Q; Zhang L
Sci Rep; 2015 Aug; 5():12668. PubMed ID: 26234610
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression.
Mishra R; Das BR
Arch Oral Biol; 2009 Oct; 54(10):917-23. PubMed ID: 19679297
[TBL] [Abstract][Full Text] [Related]
17. 1H NMR-based metabonomic and pattern recognition analysis for detection of oral squamous cell carcinoma.
Zhou J; Xu B; Huang J; Jia X; Xue J; Shi X; Xiao L; Li W
Clin Chim Acta; 2009 Mar; 401(1-2):8-13. PubMed ID: 19056370
[TBL] [Abstract][Full Text] [Related]
18. Proteomics-based identification of haptoglobin as a novel plasma biomarker in oral squamous cell carcinoma.
Lai CH; Chang NW; Lin CF; Lin CD; Lin YJ; Wan L; Sheu JJ; Chen SY; Huang YP; Sing YT; Tao TW; Lai CK; Tsai MH; Chan HL; Jou YJ; Lin CW
Clin Chim Acta; 2010 Jul; 411(13-14):984-91. PubMed ID: 20359475
[TBL] [Abstract][Full Text] [Related]
19. Expression of Mcm7 and Cdc6 in oral squamous cell carcinoma and precancerous lesions.
Feng CJ; Li HJ; Li JN; Lu YJ; Liao GQ
Anticancer Res; 2008; 28(6A):3763-9. PubMed ID: 19189662
[TBL] [Abstract][Full Text] [Related]
20. [Clinical importance of microtubule-associated protein 1 light chain 3 and mammalian target of rapamycin expression in oral leukoplakia and oral squamous cell carcinoma].
Dong XL; Liu ZW
Hua Xi Kou Qiang Yi Xue Za Zhi; 2018 Dec; 36(6):613-618. PubMed ID: 30593105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
